Advertisement

Index by author

December 01, 2000; Volume 295,Issue 3

A

  1. Abreu, Rui M. V.

    1. Effects of Carvedilol and Its Analog BM-910228 on Mitochondrial Function and Oxidative Stress
      Rui M. V. Abreu, Dario J. S. L. Santos and António J. M. Moreno
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1022-1030;

  2. Akaike, Takaaki

    1. Protective Effect of S-Nitrosylated α1-Protease Inhibitor on Hepatic Ischemia-Reperfusion Injury
      Norisato Ikebe, Takaaki Akaike, Yoichi Miyamoto, Kazuyuki Hayashida, Jun Yoshitake, Michio Ogawa and Hiroshi Maeda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 904-911;

  3. Alessio, Enzo

    1. Lack of In Vitro Cytotoxicity, Associated to Increased G2-M Cell Fraction and Inhibition of Matrigel Invasion, May Predict In Vivo-Selective Antimetastasis Activity of Ruthenium Complexes
      Sonia Zorzet, Alberta Bergamo, Moreno Cocchietto, Alenka Sorc, Barbara Gava, Enzo Alessio, Elisabetta Iengo and Gianni Sava
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 927-933;

  4. Alexander, Karen

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In Vitro Characterization and Acute Antinociceptive Effects in the Mouse
      Michael F. Jarvis, Haixia Yu, Kathy Kohlhaas, Karen Alexander, Chih-Hung Lee, Mequin Jiang, Shripad S. Bhagwat, Michael Williams and Elizabeth A. Kowaluk
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1156-1164;

  5. Allen, Richard M.

    1. Attenuation of μ-Opioid Tolerance and Cross-Tolerance by the Competitive N-Methyl-d-aspartate Receptor Antagonist LY235959 Is Related to Tolerance and Cross-Tolerance Magnitude
      Richard M. Allen and Linda A. Dykstra
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1012-1021;

  6. Anderson, Karen M.

    1. Modulation of Human Monocyte Activities by Tranilast, SB 252218, a Compound Demonstrating Efficacy in Restenosis
      Elizabeth A. Capper, Amy K. Roshak, Brian J. Bolognese, Patricia L. Podolin, Timothy Smith, David L. Dewitt, Karen M. Anderson and Lisa A. Marshall
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1061-1069;

  7. Aoki, Motonori

    1. Effect of a Novel Anti-Inflammatory Compound, YM976, on Antigen-Induced Eosinophil Infiltration into the Lungs in Rats, Mice, and Ferrets
      Motonori Aoki, Masahiro Fukunaga, Minetake Kitagawa, Kazumi Hayashi, Tatsuaki Morokata, Go Ishikawa, Satoshi Kubo and Toshimitsu Yamada
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1149-1155;

  8. Aoyama, Masashi

    1. Antidiuretic Effects of a Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Rats
      Shigeki Nakamura, Takahiro Hirano, Kenji Tsujimae, Masashi Aoyama, Kazumi Kondo, Yoshitaka Yamamura, Toyoki Mori and Michiaki Tominaga
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1005-1011;

  9. Arnhold, Thomas

    1. Metabolism of Vitamin A and Its Active Metabolite All-trans-retinoic Acid in Small Intestinal Enterocytes
      Alfonso Lampen, Silke Meyer, Thomas Arnhold and Heinz Nau
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 979-985;

  10. Artymyshyn, Roman P.

    1. Quantitative Autoradiographic Mapping of Rat Brain Dopamine D3 Binding with [125I]7-OH-PIPAT: Evidence for the Presence of D3 Receptors on Dopaminergic and Nondopaminergic Cell Bodies and Terminals
      Gregg D. Stanwood, Roman P. Artymyshyn, Mei-Ping Kung, Hank F. Kung, Irwin Lucki and Paul McGonigle
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1223-1231;

  11. Aszalos, Adorjan

    1. Influence of Antipsychotic, Antiemetic, and Ca2+Channel Blocker Drugs on the Cellular Accumulation of the Anticancer Drug Daunorubicin: P-glycoprotein Modulation
      Safaa Ibrahim, James Peggins, Alan Knapton, Thomas Licht and Adorjan Aszalos
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1276-1283;

  12. Auclair, Agnés

    1. S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Françoise Lejeune, Alain Gobert, Mauricette Brocco, Agnés Auclair, Catherine Bosc, Jean-Michel Rivet, Jean-Michel Lacoste, Alex Cordi and Anne Dekeyne
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1206-1222;

  13. Audinot, Valérie

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;

B

  1. Bailey, Blanche D.

    1. Pharmacological Profile of Recombinant, Human Activated Protein C (LY203638) in a Canine Model of Coronary Artery Thrombosis
      Charles V. Jackson, Blanche D. Bailey and Timothy J. Shetler
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 967-971;

  2. Baird, Theodore J.

    1. Natural and Artificial Enzymes Against Cocaine. I. Monoclonal Antibody 15A10 and the Reinforcing Effects of Cocaine in Rats ,
      Theodore J. Baird, Shi-Xian Deng, Donald W. Landry, Gail Winger and James H. Woods
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1127-1134;

  3. Bayley, Peter J.

    1. Anticonvulsant and Adverse Effects of Avermectin Analogs in Mice Are Mediated through the γ-Aminobutyric AcidA Receptor
      Gerard R. Dawson, Keith A. Wafford, Alison Smith, George R. Marshall, Peter J. Bayley, James M. Schaeffer, Peter T. Meinke and R. M. McKernan
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1051-1060;

  4. Beinborn, Martin

    1. Inhibition of Morphine Tolerance Development by a Substance P-Opioid Peptide Chimera
      Stacy E. Foran, Daniel B. Carr, Andrzej W. Lipkowski, Iwona Maszczynska, James E. Marchand, Aleksandra Misicka, Martin Beinborn, Alan S. Kopin and Richard M. Kream
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1142-1148;

  5. Benoit, Valérie

    1. Roles of Nuclear Factor-κB, p53, and p21/WAF1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis
      Anne-Cécile Hellin, Mohamed Bentires-Alj, Myriam Verlaet, Valérie Benoit, Jacques Gielen, Vincent Bours and Marie-Paule Merville
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 870-878;

  6. Bentires-Alj, Mohamed

    1. Roles of Nuclear Factor-κB, p53, and p21/WAF1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis
      Anne-Cécile Hellin, Mohamed Bentires-Alj, Myriam Verlaet, Valérie Benoit, Jacques Gielen, Vincent Bours and Marie-Paule Merville
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 870-878;

  7. Bergamo, Alberta

    1. Lack of In Vitro Cytotoxicity, Associated to Increased G2-M Cell Fraction and Inhibition of Matrigel Invasion, May Predict In Vivo-Selective Antimetastasis Activity of Ruthenium Complexes
      Sonia Zorzet, Alberta Bergamo, Moreno Cocchietto, Alenka Sorc, Barbara Gava, Enzo Alessio, Elisabetta Iengo and Gianni Sava
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 927-933;

  8. Bhagwat, Shripad S.

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In Vitro Characterization and Acute Antinociceptive Effects in the Mouse
      Michael F. Jarvis, Haixia Yu, Kathy Kohlhaas, Karen Alexander, Chih-Hung Lee, Mequin Jiang, Shripad S. Bhagwat, Michael Williams and Elizabeth A. Kowaluk
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1156-1164;
    2. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  9. Bloch, Wilhelm

    1. Different Effect of the Ca2+ Sensitizers EMD 57033 and CGP 48506 on Cross-Bridge Cycling in Human Myocardium
      Klara Brixius, Uwe Mehlhorn, Wilhelm Bloch and Robert H. G. Schwinger
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1284-1290;

  10. Bolognese, Brian J.

    1. Modulation of Human Monocyte Activities by Tranilast, SB 252218, a Compound Demonstrating Efficacy in Restenosis
      Elizabeth A. Capper, Amy K. Roshak, Brian J. Bolognese, Patricia L. Podolin, Timothy Smith, David L. Dewitt, Karen M. Anderson and Lisa A. Marshall
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1061-1069;

  11. Borg, Lisa

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  12. Bosc, Catherine

    1. S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Françoise Lejeune, Alain Gobert, Mauricette Brocco, Agnés Auclair, Catherine Bosc, Jean-Michel Rivet, Jean-Michel Lacoste, Alex Cordi and Anne Dekeyne
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1206-1222;

  13. Bours, Vincent

    1. Roles of Nuclear Factor-κB, p53, and p21/WAF1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis
      Anne-Cécile Hellin, Mohamed Bentires-Alj, Myriam Verlaet, Valérie Benoit, Jacques Gielen, Vincent Bours and Marie-Paule Merville
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 870-878;

  14. Boutin, Jean A.

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;

  15. Brixius, Klara

    1. Different Effect of the Ca2+ Sensitizers EMD 57033 and CGP 48506 on Cross-Bridge Cycling in Human Myocardium
      Klara Brixius, Uwe Mehlhorn, Wilhelm Bloch and Robert H. G. Schwinger
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1284-1290;

  16. Brocco, Mauricette

    1. S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Françoise Lejeune, Alain Gobert, Mauricette Brocco, Agnés Auclair, Catherine Bosc, Jean-Michel Rivet, Jean-Michel Lacoste, Alex Cordi and Anne Dekeyne
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1206-1222;

  17. Buckpitt, Alan R.

    1. Long-Term Exposure to Ozone Increases Acute Pulmonary Centriacinar Injury by 1-Nitronaphthalene: I. Region-Specific Enzyme Activity
      Renee C. Paige, Fred H. Royce, Charles G. Plopper and Alan R. Buckpitt
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 934-941;

  18. Burnstock, Geoffrey

    1. P2 Purinergic Receptors: Modulation of Cell Function and Therapeutic Potential
      Geoffrey Burnstock and Michael Williams
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 862-869;

C

  1. Campbell, Vera C.

    1. Comparison of [3H]Glyburide Binding with Opiate Analgesia, Tolerance, and Dependence in ICR and Swiss-Webster Mice
      Vera C. Campbell, William L. Dewey and Sandra P. Welch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1112-1119;

  2. Capper, Elizabeth A.

    1. Modulation of Human Monocyte Activities by Tranilast, SB 252218, a Compound Demonstrating Efficacy in Restenosis
      Elizabeth A. Capper, Amy K. Roshak, Brian J. Bolognese, Patricia L. Podolin, Timothy Smith, David L. Dewitt, Karen M. Anderson and Lisa A. Marshall
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1061-1069;

  3. Carr, Daniel B.

    1. Inhibition of Morphine Tolerance Development by a Substance P-Opioid Peptide Chimera
      Stacy E. Foran, Daniel B. Carr, Andrzej W. Lipkowski, Iwona Maszczynska, James E. Marchand, Aleksandra Misicka, Martin Beinborn, Alan S. Kopin and Richard M. Kream
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1142-1148;

  4. Carson, Richard E.

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  5. Casiano, Carlos A.

    1. Role of Mitochondrial Cytochrome c in Cocaine-Induced Apoptosis in Coronary Artery Endothelial Cells
      Jiale He, Yuhui Xiao, Carlos A. Casiano and Lubo Zhang
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 896-903;

  6. Chan, Anthony S. L.

    1. Regulation of c-Jun N-Terminal Kinase by the ORL1Receptor through Multiple G Proteins
      Anthony S. L. Chan and Yung H. Wong
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1094-1100;

  7. Chang, Qing

    1. Protein Kinase C Mediates Lipopolysaccharide- and Phorbol-Induced Nitric-Oxide Synthase Activity and Cellular Injury in the Rat Colon
      Barry L. Tepperman, Qing Chang and Brian D. Soper
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1249-1257;

  8. Chen, Chun-Lin

    1. Treatment of Allergic Asthma by Targeting Janus Kinase 3-Dependent Leukotriene Synthesis in Mast Cells with 4-(3′,5′-Dibromo-4′-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)
      Ravi Malaviya, Chun-Lin Chen, Christopher Navara, Rama Malaviya, Xing-Ping Liu, Margaret Keenan, Barbara Waurzyniak and Fatih M. Uckun
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 912-926;

  9. Chrones, Tom

    1. Pharmacological and Molecular Characterization of Muscarinic Receptor Subtypes in Human Esophageal Smooth Muscle
      Harold G. Preiksaitis, Pawel S. Krysiak, Tom Chrones, Vaishnav Rajgopal and Lisanne G. Laurier
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 879-888;

  10. Clarke, Paul B. S.

    1. Supraspinal Antinociceptive Response to [d-Pen2,5]-Enkephalin (DPDPE) Is Pharmacologically Distinct from That to Other δ-Agonists in the Rat
      Graeme L. Fraser, Amynah A. Pradhan, Paul B. S. Clarke and Claes Wahlestedt
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1135-1141;

  11. Cocchietto, Moreno

    1. Lack of In Vitro Cytotoxicity, Associated to Increased G2-M Cell Fraction and Inhibition of Matrigel Invasion, May Predict In Vivo-Selective Antimetastasis Activity of Ruthenium Complexes
      Sonia Zorzet, Alberta Bergamo, Moreno Cocchietto, Alenka Sorc, Barbara Gava, Enzo Alessio, Elisabetta Iengo and Gianni Sava
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 927-933;

  12. Cordi, Alex

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;
    2. S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Françoise Lejeune, Alain Gobert, Mauricette Brocco, Agnés Auclair, Catherine Bosc, Jean-Michel Rivet, Jean-Michel Lacoste, Alex Cordi and Anne Dekeyne
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1206-1222;

  13. Cox, Bryan F.

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  14. Cryan, John F.

    1. Antidepressant-Like Behavioral Effects Mediated by 5-Hydroxytryptamine2C Receptors
      John F. Cryan and Irwin Lucki
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1120-1126;

  15. Cussac, Didier

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;

D

  1. Danieli-Betto, Daniela

    1. Pharmacological Characterization of a New Ca2+Sensitizer
      Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 994-1004;

  2. Da Settimo, Federico

    1. Pharmacological Characterization of a New Ca2+Sensitizer
      Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 994-1004;

  3. Davis, Thomas P.

    1. Insulin Enhancement of Opioid Peptide Transport across the Blood-Brain Barrier and Assessment of Analgesic Effect
      Ken A. Witt, Jason D. Huber, Richard D. Egleton and Thomas P. Davis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 972-978;

  4. Dawson, Gerard R.

    1. Anticonvulsant and Adverse Effects of Avermectin Analogs in Mice Are Mediated through the γ-Aminobutyric AcidA Receptor
      Gerard R. Dawson, Keith A. Wafford, Alison Smith, George R. Marshall, Peter J. Bayley, James M. Schaeffer, Peter T. Meinke and R. M. McKernan
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1051-1060;

  5. Dekeyne, Anne

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;
    2. S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Françoise Lejeune, Alain Gobert, Mauricette Brocco, Agnés Auclair, Catherine Bosc, Jean-Michel Rivet, Jean-Michel Lacoste, Alex Cordi and Anne Dekeyne
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1206-1222;

  6. Deng, Shi-Xian

    1. Natural and Artificial Enzymes Against Cocaine. I. Monoclonal Antibody 15A10 and the Reinforcing Effects of Cocaine in Rats ,
      Theodore J. Baird, Shi-Xian Deng, Donald W. Landry, Gail Winger and James H. Woods
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1127-1134;

  7. Dewey, William L.

    1. Comparison of [3H]Glyburide Binding with Opiate Analgesia, Tolerance, and Dependence in ICR and Swiss-Webster Mice
      Vera C. Campbell, William L. Dewey and Sandra P. Welch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1112-1119;

  8. Dewitt, David L.

    1. Modulation of Human Monocyte Activities by Tranilast, SB 252218, a Compound Demonstrating Efficacy in Restenosis
      Elizabeth A. Capper, Amy K. Roshak, Brian J. Bolognese, Patricia L. Podolin, Timothy Smith, David L. Dewitt, Karen M. Anderson and Lisa A. Marshall
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1061-1069;

  9. Donovan, Cindy M.

    1. Stimulus-Dependent Modulation of [3H]Norepinephrine Release from Rat Neocortical Slices by Gabapentin and Pregabalin
      David J. Dooley, Cindy M. Donovan and Thomas A. Pugsley
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1086-1093;

  10. Dooley, David J.

    1. Stimulus-Dependent Modulation of [3H]Norepinephrine Release from Rat Neocortical Slices by Gabapentin and Pregabalin
      David J. Dooley, Cindy M. Donovan and Thomas A. Pugsley
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1086-1093;

  11. Dorigo, Paola

    1. Pharmacological Characterization of a New Ca2+Sensitizer
      Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 994-1004;

  12. Duqueyroix, Delphine

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;

  13. Dykstra, Linda A.

    1. Attenuation of μ-Opioid Tolerance and Cross-Tolerance by the Competitive N-Methyl-d-aspartate Receptor Antagonist LY235959 Is Related to Tolerance and Cross-Tolerance Magnitude
      Richard M. Allen and Linda A. Dykstra
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1012-1021;

E

  1. Eckelman, William C.

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  2. Egleton, Richard D.

    1. Insulin Enhancement of Opioid Peptide Transport across the Blood-Brain Barrier and Assessment of Analgesic Effect
      Ken A. Witt, Jason D. Huber, Richard D. Egleton and Thomas P. Davis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 972-978;

F

  1. Fleckenstein, Annette E.

    1. Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia ,
      Ryan R. Metzger, Heather M. Haughey, Diana G. Wilkins, James W. Gibb, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1077-1085;

  2. Fleming, William W.

    1. Alterations in Neuronal γ-Aminobutyric AcidAReceptor Responsiveness in Genetic Models of Seizure Susceptibility with Different Expression Patterns
      Lance R. Molnar, William W. Fleming and David A. Taylor
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1258-1266;

  3. Fletcher, Paul J.

    1. Studies to Investigate the Role of 5-HT2C Receptors on Cocaine- and Food-Maintained Behavior
      Andrew J. Grottick, Paul J. Fletcher and Guy A. Higgins
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1183-1191;

  4. Floreani, Maura

    1. Pharmacological Characterization of a New Ca2+Sensitizer
      Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 994-1004;

  5. Foran, Stacy E.

    1. Inhibition of Morphine Tolerance Development by a Substance P-Opioid Peptide Chimera
      Stacy E. Foran, Daniel B. Carr, Andrzej W. Lipkowski, Iwona Maszczynska, James E. Marchand, Aleksandra Misicka, Martin Beinborn, Alan S. Kopin and Richard M. Kream
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1142-1148;

  6. Fraser, Graeme L.

    1. Supraspinal Antinociceptive Response to [d-Pen2,5]-Enkephalin (DPDPE) Is Pharmacologically Distinct from That to Other δ-Agonists in the Rat
      Graeme L. Fraser, Amynah A. Pradhan, Paul B. S. Clarke and Claes Wahlestedt
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1135-1141;

  7. Fukunaga, Masahiro

    1. Effect of a Novel Anti-Inflammatory Compound, YM976, on Antigen-Induced Eosinophil Infiltration into the Lungs in Rats, Mice, and Ferrets
      Motonori Aoki, Masahiro Fukunaga, Minetake Kitagawa, Kazumi Hayashi, Tatsuaki Morokata, Go Ishikawa, Satoshi Kubo and Toshimitsu Yamada
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1149-1155;

G

  1. Gasior, Maciej

    1. Changes in the Ambulatory Activity and Discriminative Stimulus Effects of Psychostimulant Drugs in Rats Chronically Exposed to Caffeine: Effect of Caffeine Dose
      Maciej Gasior, Maria Jaszyna, Jamie Peters and Steven R. Goldberg
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1101-1111;

  2. Gasparini, Fabrizio

    1. Anxiolytic-Like Effects of the Prototypical Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)pyridine in Rodents
      Will P. J. M. Spooren, Annick Vassout, Hans C. Neijt, Rainer Kuhn, Fabrizio Gasparini, Silvain Roux, Roger D. Porsolt and Conrad Gentsch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1267-1275;

  3. Gava, Barbara

    1. Lack of In Vitro Cytotoxicity, Associated to Increased G2-M Cell Fraction and Inhibition of Matrigel Invasion, May Predict In Vivo-Selective Antimetastasis Activity of Ruthenium Complexes
      Sonia Zorzet, Alberta Bergamo, Moreno Cocchietto, Alenka Sorc, Barbara Gava, Enzo Alessio, Elisabetta Iengo and Gianni Sava
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 927-933;

  4. Gentsch, Conrad

    1. Anxiolytic-Like Effects of the Prototypical Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)pyridine in Rodents
      Will P. J. M. Spooren, Annick Vassout, Hans C. Neijt, Rainer Kuhn, Fabrizio Gasparini, Silvain Roux, Roger D. Porsolt and Conrad Gentsch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1267-1275;

  5. Germinario, Elena

    1. Pharmacological Characterization of a New Ca2+Sensitizer
      Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 994-1004;

  6. Gibb, James W.

    1. Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia ,
      Ryan R. Metzger, Heather M. Haughey, Diana G. Wilkins, James W. Gibb, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1077-1085;

  7. Gielen, Jacques

    1. Roles of Nuclear Factor-κB, p53, and p21/WAF1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis
      Anne-Cécile Hellin, Mohamed Bentires-Alj, Myriam Verlaet, Valérie Benoit, Jacques Gielen, Vincent Bours and Marie-Paule Merville
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 870-878;

  8. Girardon, Sylvie

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;

  9. Gobert, Alain

    1. S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Françoise Lejeune, Alain Gobert, Mauricette Brocco, Agnés Auclair, Catherine Bosc, Jean-Michel Rivet, Jean-Michel Lacoste, Alex Cordi and Anne Dekeyne
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1206-1222;

  10. Goldberg, Steven R.

    1. Changes in the Ambulatory Activity and Discriminative Stimulus Effects of Psychostimulant Drugs in Rats Chronically Exposed to Caffeine: Effect of Caffeine Dose
      Maciej Gasior, Maria Jaszyna, Jamie Peters and Steven R. Goldberg
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1101-1111;

  11. Gomtsyan, Arthur

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  12. Grottick, Andrew J.

    1. Studies to Investigate the Role of 5-HT2C Receptors on Cocaine- and Food-Maintained Behavior
      Andrew J. Grottick, Paul J. Fletcher and Guy A. Higgins
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1183-1191;

H

  1. Hamanishi, Ayako

    1. Repression of Activity-Dependent c-fos and Brain-Derived Neurotrophic Factor mRNA Expression by Pyrethroid Insecticides Accompanying a Decrease in Ca2+ Influx into Neurons
      Lisa Imamura, Hiroshi Hasegawa, Kaori Kurashina, Ayako Hamanishi, Akiko Tabuchi and Masaaki Tsuda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1175-1182;

  2. Hanson, Glen R.

    1. Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia ,
      Ryan R. Metzger, Heather M. Haughey, Diana G. Wilkins, James W. Gibb, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1077-1085;

  3. Hasegawa, Hiroshi

    1. Repression of Activity-Dependent c-fos and Brain-Derived Neurotrophic Factor mRNA Expression by Pyrethroid Insecticides Accompanying a Decrease in Ca2+ Influx into Neurons
      Lisa Imamura, Hiroshi Hasegawa, Kaori Kurashina, Ayako Hamanishi, Akiko Tabuchi and Masaaki Tsuda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1175-1182;

  4. Haughey, Heather M.

    1. Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia ,
      Ryan R. Metzger, Heather M. Haughey, Diana G. Wilkins, James W. Gibb, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1077-1085;

  5. Hayashi, Kazumi

    1. Effect of a Novel Anti-Inflammatory Compound, YM976, on Antigen-Induced Eosinophil Infiltration into the Lungs in Rats, Mice, and Ferrets
      Motonori Aoki, Masahiro Fukunaga, Minetake Kitagawa, Kazumi Hayashi, Tatsuaki Morokata, Go Ishikawa, Satoshi Kubo and Toshimitsu Yamada
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1149-1155;

  6. Hayashida, Kazuyuki

    1. Protective Effect of S-Nitrosylated α1-Protease Inhibitor on Hepatic Ischemia-Reperfusion Injury
      Norisato Ikebe, Takaaki Akaike, Yoichi Miyamoto, Kazuyuki Hayashida, Jun Yoshitake, Michio Ogawa and Hiroshi Maeda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 904-911;

  7. He, Jiale

    1. Role of Mitochondrial Cytochrome c in Cocaine-Induced Apoptosis in Coronary Artery Endothelial Cells
      Jiale He, Yuhui Xiao, Carlos A. Casiano and Lubo Zhang
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 896-903;

  8. Hellin, Anne-Cécile

    1. Roles of Nuclear Factor-κB, p53, and p21/WAF1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis
      Anne-Cécile Hellin, Mohamed Bentires-Alj, Myriam Verlaet, Valérie Benoit, Jacques Gielen, Vincent Bours and Marie-Paule Merville
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 870-878;

  9. Herscovitch, Peter

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  10. Higgins, Guy A.

    1. Studies to Investigate the Role of 5-HT2C Receptors on Cocaine- and Food-Maintained Behavior
      Andrew J. Grottick, Paul J. Fletcher and Guy A. Higgins
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1183-1191;

  11. Hirano, Takahiro

    1. Antidiuretic Effects of a Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Rats
      Shigeki Nakamura, Takahiro Hirano, Kenji Tsujimae, Masashi Aoyama, Kazumi Kondo, Yoshitaka Yamamura, Toyoki Mori and Michiaki Tominaga
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1005-1011;

  12. Ho, Ann

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  13. Ho, Jeffrey C.

    1. Tetrapeptide Derivatives of [d-Pen2,d-Pen5]-Enkephalin (DPDPE) Lacking an N-Terminal Tyrosine Residue Are Agonists at the μ-Opioid Receptor
      Iain J. McFadyen, Katarzyna Sobczyk-Kojiro, Michael J. Schaefer, Jeffrey C. Ho, John R. Omnaas, Henry I. Mosberg and John R. Traynor
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 960-966;

  14. Huber, Jason D.

    1. Insulin Enhancement of Opioid Peptide Transport across the Blood-Brain Barrier and Assessment of Analgesic Effect
      Ken A. Witt, Jason D. Huber, Richard D. Egleton and Thomas P. Davis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 972-978;

I

  1. Ibrahim, Safaa

    1. Influence of Antipsychotic, Antiemetic, and Ca2+Channel Blocker Drugs on the Cellular Accumulation of the Anticancer Drug Daunorubicin: P-glycoprotein Modulation
      Safaa Ibrahim, James Peggins, Alan Knapton, Thomas Licht and Adorjan Aszalos
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1276-1283;

  2. Iengo, Elisabetta

    1. Lack of In Vitro Cytotoxicity, Associated to Increased G2-M Cell Fraction and Inhibition of Matrigel Invasion, May Predict In Vivo-Selective Antimetastasis Activity of Ruthenium Complexes
      Sonia Zorzet, Alberta Bergamo, Moreno Cocchietto, Alenka Sorc, Barbara Gava, Enzo Alessio, Elisabetta Iengo and Gianni Sava
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 927-933;

  3. Ikebe, Norisato

    1. Protective Effect of S-Nitrosylated α1-Protease Inhibitor on Hepatic Ischemia-Reperfusion Injury
      Norisato Ikebe, Takaaki Akaike, Yoichi Miyamoto, Kazuyuki Hayashida, Jun Yoshitake, Michio Ogawa and Hiroshi Maeda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 904-911;

  4. Imamura, Lisa

    1. Repression of Activity-Dependent c-fos and Brain-Derived Neurotrophic Factor mRNA Expression by Pyrethroid Insecticides Accompanying a Decrease in Ca2+ Influx into Neurons
      Lisa Imamura, Hiroshi Hasegawa, Kaori Kurashina, Ayako Hamanishi, Akiko Tabuchi and Masaaki Tsuda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1175-1182;

  5. Ishii, Yuji

    1. Sequence Analyses of CYP2B Genes and Catalytic Profiles for P450s in Qdj:Sprague-Dawley Rats That Lack Response to the Phenobarbital-Mediated Induction of CYP2B2
      Hideyuki Yamada, Hiromi Matsunaga, Kazuhiro Tsuji, Sanae Matsumoto, Midori Yamamoto, Yuji Ishii, Curtis J. Omiecinski and Kazuta Oguri
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 986-993;

  6. Ishikawa, Go

    1. Effect of a Novel Anti-Inflammatory Compound, YM976, on Antigen-Induced Eosinophil Infiltration into the Lungs in Rats, Mice, and Ferrets
      Motonori Aoki, Masahiro Fukunaga, Minetake Kitagawa, Kazumi Hayashi, Tatsuaki Morokata, Go Ishikawa, Satoshi Kubo and Toshimitsu Yamada
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1149-1155;

J

  1. Jackson, Charles V.

    1. Pharmacological Profile of Recombinant, Human Activated Protein C (LY203638) in a Canine Model of Coronary Artery Thrombosis
      Charles V. Jackson, Blanche D. Bailey and Timothy J. Shetler
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 967-971;

  2. Jarvis, Michael F.

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In Vitro Characterization and Acute Antinociceptive Effects in the Mouse
      Michael F. Jarvis, Haixia Yu, Kathy Kohlhaas, Karen Alexander, Chih-Hung Lee, Mequin Jiang, Shripad S. Bhagwat, Michael Williams and Elizabeth A. Kowaluk
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1156-1164;
    2. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  3. Jaszyna, Maria

    1. Changes in the Ambulatory Activity and Discriminative Stimulus Effects of Psychostimulant Drugs in Rats Chronically Exposed to Caffeine: Effect of Caffeine Dose
      Maciej Gasior, Maria Jaszyna, Jamie Peters and Steven R. Goldberg
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1101-1111;

  4. Jiang, Meiqun

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  5. Jiang, Mequin

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In Vitro Characterization and Acute Antinociceptive Effects in the Mouse
      Michael F. Jarvis, Haixia Yu, Kathy Kohlhaas, Karen Alexander, Chih-Hung Lee, Mequin Jiang, Shripad S. Bhagwat, Michael Williams and Elizabeth A. Kowaluk
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1156-1164;

K

  1. Keenan, Margaret

    1. Treatment of Allergic Asthma by Targeting Janus Kinase 3-Dependent Leukotriene Synthesis in Mast Cells with 4-(3′,5′-Dibromo-4′-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)
      Ravi Malaviya, Chun-Lin Chen, Christopher Navara, Rama Malaviya, Xing-Ping Liu, Margaret Keenan, Barbara Waurzyniak and Fatih M. Uckun
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 912-926;

  2. Kitagawa, Minetake

    1. Effect of a Novel Anti-Inflammatory Compound, YM976, on Antigen-Induced Eosinophil Infiltration into the Lungs in Rats, Mice, and Ferrets
      Motonori Aoki, Masahiro Fukunaga, Minetake Kitagawa, Kazumi Hayashi, Tatsuaki Morokata, Go Ishikawa, Satoshi Kubo and Toshimitsu Yamada
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1149-1155;

  3. Kling, Mitchel A.

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  4. Knapton, Alan

    1. Influence of Antipsychotic, Antiemetic, and Ca2+Channel Blocker Drugs on the Cellular Accumulation of the Anticancer Drug Daunorubicin: P-glycoprotein Modulation
      Safaa Ibrahim, James Peggins, Alan Knapton, Thomas Licht and Adorjan Aszalos
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1276-1283;

  5. Kohlhaas, Kathy

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In Vitro Characterization and Acute Antinociceptive Effects in the Mouse
      Michael F. Jarvis, Haixia Yu, Kathy Kohlhaas, Karen Alexander, Chih-Hung Lee, Mequin Jiang, Shripad S. Bhagwat, Michael Williams and Elizabeth A. Kowaluk
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1156-1164;

  6. Kondo, Kazumi

    1. Antidiuretic Effects of a Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Rats
      Shigeki Nakamura, Takahiro Hirano, Kenji Tsujimae, Masashi Aoyama, Kazumi Kondo, Yoshitaka Yamamura, Toyoki Mori and Michiaki Tominaga
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1005-1011;

  7. Kopin, Alan S.

    1. Inhibition of Morphine Tolerance Development by a Substance P-Opioid Peptide Chimera
      Stacy E. Foran, Daniel B. Carr, Andrzej W. Lipkowski, Iwona Maszczynska, James E. Marchand, Aleksandra Misicka, Martin Beinborn, Alan S. Kopin and Richard M. Kream
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1142-1148;

  8. Kowaluk, Elizabeth A.

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In Vitro Characterization and Acute Antinociceptive Effects in the Mouse
      Michael F. Jarvis, Haixia Yu, Kathy Kohlhaas, Karen Alexander, Chih-Hung Lee, Mequin Jiang, Shripad S. Bhagwat, Michael Williams and Elizabeth A. Kowaluk
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1156-1164;
    2. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  9. Kream, Richard M.

    1. Inhibition of Morphine Tolerance Development by a Substance P-Opioid Peptide Chimera
      Stacy E. Foran, Daniel B. Carr, Andrzej W. Lipkowski, Iwona Maszczynska, James E. Marchand, Aleksandra Misicka, Martin Beinborn, Alan S. Kopin and Richard M. Kream
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1142-1148;

  10. Kreek, Mary Jeanne

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  11. Krysiak, Pawel S.

    1. Pharmacological and Molecular Characterization of Muscarinic Receptor Subtypes in Human Esophageal Smooth Muscle
      Harold G. Preiksaitis, Pawel S. Krysiak, Tom Chrones, Vaishnav Rajgopal and Lisanne G. Laurier
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 879-888;

  12. Kubo, Satoshi

    1. Effect of a Novel Anti-Inflammatory Compound, YM976, on Antigen-Induced Eosinophil Infiltration into the Lungs in Rats, Mice, and Ferrets
      Motonori Aoki, Masahiro Fukunaga, Minetake Kitagawa, Kazumi Hayashi, Tatsuaki Morokata, Go Ishikawa, Satoshi Kubo and Toshimitsu Yamada
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1149-1155;

  13. Kuhn, Rainer

    1. Anxiolytic-Like Effects of the Prototypical Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)pyridine in Rodents
      Will P. J. M. Spooren, Annick Vassout, Hans C. Neijt, Rainer Kuhn, Fabrizio Gasparini, Silvain Roux, Roger D. Porsolt and Conrad Gentsch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1267-1275;

  14. Kung, Hank F.

    1. Quantitative Autoradiographic Mapping of Rat Brain Dopamine D3 Binding with [125I]7-OH-PIPAT: Evidence for the Presence of D3 Receptors on Dopaminergic and Nondopaminergic Cell Bodies and Terminals
      Gregg D. Stanwood, Roman P. Artymyshyn, Mei-Ping Kung, Hank F. Kung, Irwin Lucki and Paul McGonigle
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1223-1231;

  15. Kung, Mei-Ping

    1. Quantitative Autoradiographic Mapping of Rat Brain Dopamine D3 Binding with [125I]7-OH-PIPAT: Evidence for the Presence of D3 Receptors on Dopaminergic and Nondopaminergic Cell Bodies and Terminals
      Gregg D. Stanwood, Roman P. Artymyshyn, Mei-Ping Kung, Hank F. Kung, Irwin Lucki and Paul McGonigle
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1223-1231;

  16. Kurashina, Kaori

    1. Repression of Activity-Dependent c-fos and Brain-Derived Neurotrophic Factor mRNA Expression by Pyrethroid Insecticides Accompanying a Decrease in Ca2+ Influx into Neurons
      Lisa Imamura, Hiroshi Hasegawa, Kaori Kurashina, Ayako Hamanishi, Akiko Tabuchi and Masaaki Tsuda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1175-1182;

  17. Kuzmin, Alexander

    1. Dose- and Time-Dependent Bimodal Effects of κ-Opioid Agonists on Locomotor Activity in Mice
      Alexander Kuzmin, Johan Sandin, Lars Terenius and Sven-Ove Ögren
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1031-1042;

L

  1. Lacoste, Jean-Michel

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;
    2. S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Françoise Lejeune, Alain Gobert, Mauricette Brocco, Agnés Auclair, Catherine Bosc, Jean-Michel Rivet, Jean-Michel Lacoste, Alex Cordi and Anne Dekeyne
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1206-1222;

  2. Lampen, Alfonso

    1. Metabolism of Vitamin A and Its Active Metabolite All-trans-retinoic Acid in Small Intestinal Enterocytes
      Alfonso Lampen, Silke Meyer, Thomas Arnhold and Heinz Nau
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 979-985;

  3. Landry, Donald W.

    1. Natural and Artificial Enzymes Against Cocaine. I. Monoclonal Antibody 15A10 and the Reinforcing Effects of Cocaine in Rats ,
      Theodore J. Baird, Shi-Xian Deng, Donald W. Landry, Gail Winger and James H. Woods
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1127-1134;

  4. Laurier, Lisanne G.

    1. Pharmacological and Molecular Characterization of Muscarinic Receptor Subtypes in Human Esophageal Smooth Muscle
      Harold G. Preiksaitis, Pawel S. Krysiak, Tom Chrones, Vaishnav Rajgopal and Lisanne G. Laurier
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 879-888;

  5. Lee, Chih-Hung

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In Vitro Characterization and Acute Antinociceptive Effects in the Mouse
      Michael F. Jarvis, Haixia Yu, Kathy Kohlhaas, Karen Alexander, Chih-Hung Lee, Mequin Jiang, Shripad S. Bhagwat, Michael Williams and Elizabeth A. Kowaluk
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1156-1164;
    2. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  6. Lejeune, Françoise

    1. S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Françoise Lejeune, Alain Gobert, Mauricette Brocco, Agnés Auclair, Catherine Bosc, Jean-Michel Rivet, Jean-Michel Lacoste, Alex Cordi and Anne Dekeyne
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1206-1222;

  7. Li, Jing

    1. Regulation of the Human Norepinephrine Transporter by Cocaine and Amphetamine
      Meng-Yang Zhu, Susan Shamburger, Jing Li and Gregory A. Ordway
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 951-959;

  8. Licht, Thomas

    1. Influence of Antipsychotic, Antiemetic, and Ca2+Channel Blocker Drugs on the Cellular Accumulation of the Anticancer Drug Daunorubicin: P-glycoprotein Modulation
      Safaa Ibrahim, James Peggins, Alan Knapton, Thomas Licht and Adorjan Aszalos
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1276-1283;

  9. Lipkowski, Andrzej W.

    1. Inhibition of Morphine Tolerance Development by a Substance P-Opioid Peptide Chimera
      Stacy E. Foran, Daniel B. Carr, Andrzej W. Lipkowski, Iwona Maszczynska, James E. Marchand, Aleksandra Misicka, Martin Beinborn, Alan S. Kopin and Richard M. Kream
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1142-1148;

  10. Liu, Xing-Ping

    1. Treatment of Allergic Asthma by Targeting Janus Kinase 3-Dependent Leukotriene Synthesis in Mast Cells with 4-(3′,5′-Dibromo-4′-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)
      Ravi Malaviya, Chun-Lin Chen, Christopher Navara, Rama Malaviya, Xing-Ping Liu, Margaret Keenan, Barbara Waurzyniak and Fatih M. Uckun
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 912-926;

  11. Lucki, Irwin

    1. Antidepressant-Like Behavioral Effects Mediated by 5-Hydroxytryptamine2C Receptors
      John F. Cryan and Irwin Lucki
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1120-1126;
    2. Quantitative Autoradiographic Mapping of Rat Brain Dopamine D3 Binding with [125I]7-OH-PIPAT: Evidence for the Presence of D3 Receptors on Dopaminergic and Nondopaminergic Cell Bodies and Terminals
      Gregg D. Stanwood, Roman P. Artymyshyn, Mei-Ping Kung, Hank F. Kung, Irwin Lucki and Paul McGonigle
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1223-1231;
    3. Differential Regulation of Dopamine D2 and D3 Receptors by Chronic Drug Treatments
      Gregg D. Stanwood, Irwin Lucki and Paul McGonigle
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1232-1240;

  12. Lynch, James J.

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

M

  1. Maeda, Hiroshi

    1. Protective Effect of S-Nitrosylated α1-Protease Inhibitor on Hepatic Ischemia-Reperfusion Injury
      Norisato Ikebe, Takaaki Akaike, Yoichi Miyamoto, Kazuyuki Hayashida, Jun Yoshitake, Michio Ogawa and Hiroshi Maeda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 904-911;

  2. Magno, Sebastiano Marciani

    1. Pharmacological Characterization of a New Ca2+Sensitizer
      Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 994-1004;

  3. Malaviya, Rama

    1. Treatment of Allergic Asthma by Targeting Janus Kinase 3-Dependent Leukotriene Synthesis in Mast Cells with 4-(3′,5′-Dibromo-4′-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)
      Ravi Malaviya, Chun-Lin Chen, Christopher Navara, Rama Malaviya, Xing-Ping Liu, Margaret Keenan, Barbara Waurzyniak and Fatih M. Uckun
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 912-926;

  4. Malaviya, Ravi

    1. Treatment of Allergic Asthma by Targeting Janus Kinase 3-Dependent Leukotriene Synthesis in Mast Cells with 4-(3′,5′-Dibromo-4′-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)
      Ravi Malaviya, Chun-Lin Chen, Christopher Navara, Rama Malaviya, Xing-Ping Liu, Margaret Keenan, Barbara Waurzyniak and Fatih M. Uckun
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 912-926;

  5. Maragno, Ildebrando

    1. Pharmacological Characterization of a New Ca2+Sensitizer
      Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 994-1004;

  6. Marchand, James E.

    1. Inhibition of Morphine Tolerance Development by a Substance P-Opioid Peptide Chimera
      Stacy E. Foran, Daniel B. Carr, Andrzej W. Lipkowski, Iwona Maszczynska, James E. Marchand, Aleksandra Misicka, Martin Beinborn, Alan S. Kopin and Richard M. Kream
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1142-1148;

  7. Marini, Anna Maria

    1. Pharmacological Characterization of a New Ca2+Sensitizer
      Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 994-1004;

  8. Marshall, George R.

    1. Anticonvulsant and Adverse Effects of Avermectin Analogs in Mice Are Mediated through the γ-Aminobutyric AcidA Receptor
      Gerard R. Dawson, Keith A. Wafford, Alison Smith, George R. Marshall, Peter J. Bayley, James M. Schaeffer, Peter T. Meinke and R. M. McKernan
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1051-1060;

  9. Marshall, Lisa A.

    1. Modulation of Human Monocyte Activities by Tranilast, SB 252218, a Compound Demonstrating Efficacy in Restenosis
      Elizabeth A. Capper, Amy K. Roshak, Brian J. Bolognese, Patricia L. Podolin, Timothy Smith, David L. Dewitt, Karen M. Anderson and Lisa A. Marshall
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1061-1069;

  10. Maszczynska, Iwona

    1. Inhibition of Morphine Tolerance Development by a Substance P-Opioid Peptide Chimera
      Stacy E. Foran, Daniel B. Carr, Andrzej W. Lipkowski, Iwona Maszczynska, James E. Marchand, Aleksandra Misicka, Martin Beinborn, Alan S. Kopin and Richard M. Kream
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1142-1148;

  11. Matochik, John A.

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  12. Matsumoto, Sanae

    1. Sequence Analyses of CYP2B Genes and Catalytic Profiles for P450s in Qdj:Sprague-Dawley Rats That Lack Response to the Phenobarbital-Mediated Induction of CYP2B2
      Hideyuki Yamada, Hiromi Matsunaga, Kazuhiro Tsuji, Sanae Matsumoto, Midori Yamamoto, Yuji Ishii, Curtis J. Omiecinski and Kazuta Oguri
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 986-993;

  13. Matsunaga, Hiromi

    1. Sequence Analyses of CYP2B Genes and Catalytic Profiles for P450s in Qdj:Sprague-Dawley Rats That Lack Response to the Phenobarbital-Mediated Induction of CYP2B2
      Hideyuki Yamada, Hiromi Matsunaga, Kazuhiro Tsuji, Sanae Matsumoto, Midori Yamamoto, Yuji Ishii, Curtis J. Omiecinski and Kazuta Oguri
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 986-993;

  14. Matsuura, Naosuke

    1. Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery
      Eiji Sasaki, Yasutaka Tanahashi, Yasundo Yamasaki, Nobuyuki Oda, Yoshihisa Nozawa, Hiroshi Terakawa, Kazuhisa Miyoshi, Yoshiyuki Muranaka, Hidekazu Miyake and Naosuke Matsuura
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1043-1050;

  15. McFadyen, Iain J.

    1. Tetrapeptide Derivatives of [d-Pen2,d-Pen5]-Enkephalin (DPDPE) Lacking an N-Terminal Tyrosine Residue Are Agonists at the μ-Opioid Receptor
      Iain J. McFadyen, Katarzyna Sobczyk-Kojiro, Michael J. Schaefer, Jeffrey C. Ho, John R. Omnaas, Henry I. Mosberg and John R. Traynor
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 960-966;

  16. McGonigle, Paul

    1. Quantitative Autoradiographic Mapping of Rat Brain Dopamine D3 Binding with [125I]7-OH-PIPAT: Evidence for the Presence of D3 Receptors on Dopaminergic and Nondopaminergic Cell Bodies and Terminals
      Gregg D. Stanwood, Roman P. Artymyshyn, Mei-Ping Kung, Hank F. Kung, Irwin Lucki and Paul McGonigle
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1223-1231;
    2. Differential Regulation of Dopamine D2 and D3 Receptors by Chronic Drug Treatments
      Gregg D. Stanwood, Irwin Lucki and Paul McGonigle
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1232-1240;

  17. McKernan, R. M.

    1. Anticonvulsant and Adverse Effects of Avermectin Analogs in Mice Are Mediated through the γ-Aminobutyric AcidA Receptor
      Gerard R. Dawson, Keith A. Wafford, Alison Smith, George R. Marshall, Peter J. Bayley, James M. Schaeffer, Peter T. Meinke and R. M. McKernan
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1051-1060;

  18. McKie, Jeff

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  19. Mehlhorn, Uwe

    1. Different Effect of the Ca2+ Sensitizers EMD 57033 and CGP 48506 on Cross-Bridge Cycling in Human Myocardium
      Klara Brixius, Uwe Mehlhorn, Wilhelm Bloch and Robert H. G. Schwinger
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1284-1290;

  20. Meinke, Peter T.

    1. Anticonvulsant and Adverse Effects of Avermectin Analogs in Mice Are Mediated through the γ-Aminobutyric AcidA Receptor
      Gerard R. Dawson, Keith A. Wafford, Alison Smith, George R. Marshall, Peter J. Bayley, James M. Schaeffer, Peter T. Meinke and R. M. McKernan
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1051-1060;

  21. Merville, Marie-Paule

    1. Roles of Nuclear Factor-κB, p53, and p21/WAF1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis
      Anne-Cécile Hellin, Mohamed Bentires-Alj, Myriam Verlaet, Valérie Benoit, Jacques Gielen, Vincent Bours and Marie-Paule Merville
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 870-878;

  22. Metzger, Ryan R.

    1. Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia ,
      Ryan R. Metzger, Heather M. Haughey, Diana G. Wilkins, James W. Gibb, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1077-1085;

  23. Meyer, Silke

    1. Metabolism of Vitamin A and Its Active Metabolite All-trans-retinoic Acid in Small Intestinal Enterocytes
      Alfonso Lampen, Silke Meyer, Thomas Arnhold and Heinz Nau
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 979-985;

  24. Mikusa, Joe

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  25. Millan, Mark J.

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;
    2. S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Françoise Lejeune, Alain Gobert, Mauricette Brocco, Agnés Auclair, Catherine Bosc, Jean-Michel Rivet, Jean-Michel Lacoste, Alex Cordi and Anne Dekeyne
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1206-1222;
    3. Improving the Treatment of Schizophrenia: Focus on Serotonin (5-HT)1A Receptors
      Mark J. Millan
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 853-861;

  26. Milligan, Graeme

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;

  27. Misicka, Aleksandra

    1. Inhibition of Morphine Tolerance Development by a Substance P-Opioid Peptide Chimera
      Stacy E. Foran, Daniel B. Carr, Andrzej W. Lipkowski, Iwona Maszczynska, James E. Marchand, Aleksandra Misicka, Martin Beinborn, Alan S. Kopin and Richard M. Kream
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1142-1148;

  28. Miyake, Hidekazu

    1. Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery
      Eiji Sasaki, Yasutaka Tanahashi, Yasundo Yamasaki, Nobuyuki Oda, Yoshihisa Nozawa, Hiroshi Terakawa, Kazuhisa Miyoshi, Yoshiyuki Muranaka, Hidekazu Miyake and Naosuke Matsuura
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1043-1050;

  29. Miyamoto, Yoichi

    1. Protective Effect of S-Nitrosylated α1-Protease Inhibitor on Hepatic Ischemia-Reperfusion Injury
      Norisato Ikebe, Takaaki Akaike, Yoichi Miyamoto, Kazuyuki Hayashida, Jun Yoshitake, Michio Ogawa and Hiroshi Maeda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 904-911;

  30. Miyoshi, Kazuhisa

    1. Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery
      Eiji Sasaki, Yasutaka Tanahashi, Yasundo Yamasaki, Nobuyuki Oda, Yoshihisa Nozawa, Hiroshi Terakawa, Kazuhisa Miyoshi, Yoshiyuki Muranaka, Hidekazu Miyake and Naosuke Matsuura
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1043-1050;

  31. Molnar, Lance R.

    1. Alterations in Neuronal γ-Aminobutyric AcidAReceptor Responsiveness in Genetic Models of Seizure Susceptibility with Different Expression Patterns
      Lance R. Molnar, William W. Fleming and David A. Taylor
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1258-1266;

  32. Moreno, António J. M.

    1. Effects of Carvedilol and Its Analog BM-910228 on Mitochondrial Function and Oxidative Stress
      Rui M. V. Abreu, Dario J. S. L. Santos and António J. M. Moreno
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1022-1030;

  33. Mori, Toyoki

    1. Antidiuretic Effects of a Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Rats
      Shigeki Nakamura, Takahiro Hirano, Kenji Tsujimae, Masashi Aoyama, Kazumi Kondo, Yoshitaka Yamamura, Toyoki Mori and Michiaki Tominaga
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1005-1011;

  34. Morokata, Tatsuaki

    1. Effect of a Novel Anti-Inflammatory Compound, YM976, on Antigen-Induced Eosinophil Infiltration into the Lungs in Rats, Mice, and Ferrets
      Motonori Aoki, Masahiro Fukunaga, Minetake Kitagawa, Kazumi Hayashi, Tatsuaki Morokata, Go Ishikawa, Satoshi Kubo and Toshimitsu Yamada
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1149-1155;

  35. Mosberg, Henry I.

    1. Tetrapeptide Derivatives of [d-Pen2,d-Pen5]-Enkephalin (DPDPE) Lacking an N-Terminal Tyrosine Residue Are Agonists at the μ-Opioid Receptor
      Iain J. McFadyen, Katarzyna Sobczyk-Kojiro, Michael J. Schaefer, Jeffrey C. Ho, John R. Omnaas, Henry I. Mosberg and John R. Traynor
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 960-966;

  36. Mullot, Jimmy

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;

  37. Muranaka, Yoshiyuki

    1. Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery
      Eiji Sasaki, Yasutaka Tanahashi, Yasundo Yamasaki, Nobuyuki Oda, Yoshihisa Nozawa, Hiroshi Terakawa, Kazuhisa Miyoshi, Yoshiyuki Muranaka, Hidekazu Miyake and Naosuke Matsuura
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1043-1050;

N

  1. Nakamura, Shigeki

    1. Antidiuretic Effects of a Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Rats
      Shigeki Nakamura, Takahiro Hirano, Kenji Tsujimae, Masashi Aoyama, Kazumi Kondo, Yoshitaka Yamamura, Toyoki Mori and Michiaki Tominaga
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1005-1011;

  2. Nau, Heinz

    1. Metabolism of Vitamin A and Its Active Metabolite All-trans-retinoic Acid in Small Intestinal Enterocytes
      Alfonso Lampen, Silke Meyer, Thomas Arnhold and Heinz Nau
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 979-985;

  3. Navara, Christopher

    1. Treatment of Allergic Asthma by Targeting Janus Kinase 3-Dependent Leukotriene Synthesis in Mast Cells with 4-(3′,5′-Dibromo-4′-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)
      Ravi Malaviya, Chun-Lin Chen, Christopher Navara, Rama Malaviya, Xing-Ping Liu, Margaret Keenan, Barbara Waurzyniak and Fatih M. Uckun
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 912-926;

  4. Neijt, Hans C.

    1. Anxiolytic-Like Effects of the Prototypical Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)pyridine in Rodents
      Will P. J. M. Spooren, Annick Vassout, Hans C. Neijt, Rainer Kuhn, Fabrizio Gasparini, Silvain Roux, Roger D. Porsolt and Conrad Gentsch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1267-1275;

  5. Newman-Tancredi, Adrian

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;

  6. Nicolas, Jean-Paul

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;

  7. Nozawa, Yoshihisa

    1. Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery
      Eiji Sasaki, Yasutaka Tanahashi, Yasundo Yamasaki, Nobuyuki Oda, Yoshihisa Nozawa, Hiroshi Terakawa, Kazuhisa Miyoshi, Yoshiyuki Muranaka, Hidekazu Miyake and Naosuke Matsuura
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1043-1050;

O

  1. Oda, Nobuyuki

    1. Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery
      Eiji Sasaki, Yasutaka Tanahashi, Yasundo Yamasaki, Nobuyuki Oda, Yoshihisa Nozawa, Hiroshi Terakawa, Kazuhisa Miyoshi, Yoshiyuki Muranaka, Hidekazu Miyake and Naosuke Matsuura
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1043-1050;

  2. Ogawa, Michio

    1. Protective Effect of S-Nitrosylated α1-Protease Inhibitor on Hepatic Ischemia-Reperfusion Injury
      Norisato Ikebe, Takaaki Akaike, Yoichi Miyamoto, Kazuyuki Hayashida, Jun Yoshitake, Michio Ogawa and Hiroshi Maeda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 904-911;

  3. Ögren, Sven-Ove

    1. Dose- and Time-Dependent Bimodal Effects of κ-Opioid Agonists on Locomotor Activity in Mice
      Alexander Kuzmin, Johan Sandin, Lars Terenius and Sven-Ove Ögren
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1031-1042;

  4. Oguri, Kazuta

    1. Sequence Analyses of CYP2B Genes and Catalytic Profiles for P450s in Qdj:Sprague-Dawley Rats That Lack Response to the Phenobarbital-Mediated Induction of CYP2B2
      Hideyuki Yamada, Hiromi Matsunaga, Kazuhiro Tsuji, Sanae Matsumoto, Midori Yamamoto, Yuji Ishii, Curtis J. Omiecinski and Kazuta Oguri
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 986-993;

  5. Omiecinski, Curtis J.

    1. Sequence Analyses of CYP2B Genes and Catalytic Profiles for P450s in Qdj:Sprague-Dawley Rats That Lack Response to the Phenobarbital-Mediated Induction of CYP2B2
      Hideyuki Yamada, Hiromi Matsunaga, Kazuhiro Tsuji, Sanae Matsumoto, Midori Yamamoto, Yuji Ishii, Curtis J. Omiecinski and Kazuta Oguri
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 986-993;

  6. Omnaas, John R.

    1. Tetrapeptide Derivatives of [d-Pen2,d-Pen5]-Enkephalin (DPDPE) Lacking an N-Terminal Tyrosine Residue Are Agonists at the μ-Opioid Receptor
      Iain J. McFadyen, Katarzyna Sobczyk-Kojiro, Michael J. Schaefer, Jeffrey C. Ho, John R. Omnaas, Henry I. Mosberg and John R. Traynor
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 960-966;

  7. Ordway, Gregory A.

    1. Regulation of the Human Norepinephrine Transporter by Cocaine and Amphetamine
      Meng-Yang Zhu, Susan Shamburger, Jing Li and Gregory A. Ordway
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 951-959;

P

  1. Paige, Renee C.

    1. Long-Term Exposure to Ozone Increases Acute Pulmonary Centriacinar Injury by 1-Nitronaphthalene: I. Region-Specific Enzyme Activity
      Renee C. Paige, Fred H. Royce, Charles G. Plopper and Alan R. Buckpitt
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 934-941;
    2. Long-Term Exposure to Ozone Increases Acute Pulmonary Centriacinar Injury by 1-Nitronaphthalene: II. Quantitative Histopathology
      Renee C. Paige, Viviana Wong and Charles G. Plopper
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 942-950;

  2. Peggins, James

    1. Influence of Antipsychotic, Antiemetic, and Ca2+Channel Blocker Drugs on the Cellular Accumulation of the Anticancer Drug Daunorubicin: P-glycoprotein Modulation
      Safaa Ibrahim, James Peggins, Alan Knapton, Thomas Licht and Adorjan Aszalos
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1276-1283;

  3. Peters, Jamie

    1. Changes in the Ambulatory Activity and Discriminative Stimulus Effects of Psychostimulant Drugs in Rats Chronically Exposed to Caffeine: Effect of Caffeine Dose
      Maciej Gasior, Maria Jaszyna, Jamie Peters and Steven R. Goldberg
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1101-1111;

  4. Plopper, Charles G.

    1. Long-Term Exposure to Ozone Increases Acute Pulmonary Centriacinar Injury by 1-Nitronaphthalene: I. Region-Specific Enzyme Activity
      Renee C. Paige, Fred H. Royce, Charles G. Plopper and Alan R. Buckpitt
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 934-941;
    2. Long-Term Exposure to Ozone Increases Acute Pulmonary Centriacinar Injury by 1-Nitronaphthalene: II. Quantitative Histopathology
      Renee C. Paige, Viviana Wong and Charles G. Plopper
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 942-950;

  5. Podolin, Patricia L.

    1. Modulation of Human Monocyte Activities by Tranilast, SB 252218, a Compound Demonstrating Efficacy in Restenosis
      Elizabeth A. Capper, Amy K. Roshak, Brian J. Bolognese, Patricia L. Podolin, Timothy Smith, David L. Dewitt, Karen M. Anderson and Lisa A. Marshall
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1061-1069;

  6. Polakowski, James

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  7. Porcari, Anthony R.

    1. Meeting Report of the ASPET Colloquium: Functional Genomics
      Anthony R. Porcari and Ronald J. Shebuski
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1291-1295;

  8. Porsolt, Roger D.

    1. Anxiolytic-Like Effects of the Prototypical Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)pyridine in Rodents
      Will P. J. M. Spooren, Annick Vassout, Hans C. Neijt, Rainer Kuhn, Fabrizio Gasparini, Silvain Roux, Roger D. Porsolt and Conrad Gentsch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1267-1275;

  9. Pradhan, Amynah A.

    1. Supraspinal Antinociceptive Response to [d-Pen2,5]-Enkephalin (DPDPE) Is Pharmacologically Distinct from That to Other δ-Agonists in the Rat
      Graeme L. Fraser, Amynah A. Pradhan, Paul B. S. Clarke and Claes Wahlestedt
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1135-1141;

  10. Preiksaitis, Harold G.

    1. Pharmacological and Molecular Characterization of Muscarinic Receptor Subtypes in Human Esophageal Smooth Muscle
      Harold G. Preiksaitis, Pawel S. Krysiak, Tom Chrones, Vaishnav Rajgopal and Lisanne G. Laurier
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 879-888;

  11. Primofiore, Gianpaolo

    1. Pharmacological Characterization of a New Ca2+Sensitizer
      Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 994-1004;

  12. Pugsley, Thomas A.

    1. Stimulus-Dependent Modulation of [3H]Norepinephrine Release from Rat Neocortical Slices by Gabapentin and Pregabalin
      David J. Dooley, Cindy M. Donovan and Thomas A. Pugsley
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1086-1093;

R

  1. Rajgopal, Vaishnav

    1. Pharmacological and Molecular Characterization of Muscarinic Receptor Subtypes in Human Esophageal Smooth Muscle
      Harold G. Preiksaitis, Pawel S. Krysiak, Tom Chrones, Vaishnav Rajgopal and Lisanne G. Laurier
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 879-888;

  2. Reddy, Doodipala S.

    1. Chronic Treatment with the Neuroactive Steroid Ganaxolone in the Rat Induces Anticonvulsant Tolerance to Diazepam but Not to Itself
      Doodipala S. Reddy and Michael A. Rogawski
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1241-1248;

  3. Reinhart, Glenn

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  4. Renouard-Try, Anne

    1. S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Anne Dekeyne, Adrian Newman-Tancredi, Didier Cussac, Valérie Audinot, Graeme Milligan, Delphine Duqueyroix, Sylvie Girardon, Jimmy Mullot, Jean A. Boutin, Jean-Paul Nicolas, Anne Renouard-Try, Jean-Michel Lacoste and Alex Cordi
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1192-1205;

  5. Rice, Kenner C.

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  6. Rivet, Jean-Michel

    1. S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
      Mark J. Millan, Françoise Lejeune, Alain Gobert, Mauricette Brocco, Agnés Auclair, Catherine Bosc, Jean-Michel Rivet, Jean-Michel Lacoste, Alex Cordi and Anne Dekeyne
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1206-1222;

  7. Rogawski, Michael A.

    1. Chronic Treatment with the Neuroactive Steroid Ganaxolone in the Rat Induces Anticonvulsant Tolerance to Diazepam but Not to Itself
      Doodipala S. Reddy and Michael A. Rogawski
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1241-1248;

  8. Roshak, Amy K.

    1. Modulation of Human Monocyte Activities by Tranilast, SB 252218, a Compound Demonstrating Efficacy in Restenosis
      Elizabeth A. Capper, Amy K. Roshak, Brian J. Bolognese, Patricia L. Podolin, Timothy Smith, David L. Dewitt, Karen M. Anderson and Lisa A. Marshall
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1061-1069;

  9. Roux, Silvain

    1. Anxiolytic-Like Effects of the Prototypical Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)pyridine in Rodents
      Will P. J. M. Spooren, Annick Vassout, Hans C. Neijt, Rainer Kuhn, Fabrizio Gasparini, Silvain Roux, Roger D. Porsolt and Conrad Gentsch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1267-1275;

  10. Royce, Fred H.

    1. Long-Term Exposure to Ozone Increases Acute Pulmonary Centriacinar Injury by 1-Nitronaphthalene: I. Region-Specific Enzyme Activity
      Renee C. Paige, Fred H. Royce, Charles G. Plopper and Alan R. Buckpitt
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 934-941;

S

  1. Sandin, Johan

    1. Dose- and Time-Dependent Bimodal Effects of κ-Opioid Agonists on Locomotor Activity in Mice
      Alexander Kuzmin, Johan Sandin, Lars Terenius and Sven-Ove Ögren
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1031-1042;

  2. Santos, Dario J. S. L.

    1. Effects of Carvedilol and Its Analog BM-910228 on Mitochondrial Function and Oxidative Stress
      Rui M. V. Abreu, Dario J. S. L. Santos and António J. M. Moreno
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1022-1030;

  3. Santostasi, Giovanni

    1. Pharmacological Characterization of a New Ca2+Sensitizer
      Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 994-1004;

  4. Sasaki, Eiji

    1. Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery
      Eiji Sasaki, Yasutaka Tanahashi, Yasundo Yamasaki, Nobuyuki Oda, Yoshihisa Nozawa, Hiroshi Terakawa, Kazuhisa Miyoshi, Yoshiyuki Muranaka, Hidekazu Miyake and Naosuke Matsuura
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1043-1050;

  5. Sava, Gianni

    1. Lack of In Vitro Cytotoxicity, Associated to Increased G2-M Cell Fraction and Inhibition of Matrigel Invasion, May Predict In Vivo-Selective Antimetastasis Activity of Ruthenium Complexes
      Sonia Zorzet, Alberta Bergamo, Moreno Cocchietto, Alenka Sorc, Barbara Gava, Enzo Alessio, Elisabetta Iengo and Gianni Sava
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 927-933;

  6. Schaefer, Michael J.

    1. Tetrapeptide Derivatives of [d-Pen2,d-Pen5]-Enkephalin (DPDPE) Lacking an N-Terminal Tyrosine Residue Are Agonists at the μ-Opioid Receptor
      Iain J. McFadyen, Katarzyna Sobczyk-Kojiro, Michael J. Schaefer, Jeffrey C. Ho, John R. Omnaas, Henry I. Mosberg and John R. Traynor
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 960-966;

  7. Schaeffer, James M.

    1. Anticonvulsant and Adverse Effects of Avermectin Analogs in Mice Are Mediated through the γ-Aminobutyric AcidA Receptor
      Gerard R. Dawson, Keith A. Wafford, Alison Smith, George R. Marshall, Peter J. Bayley, James M. Schaeffer, Peter T. Meinke and R. M. McKernan
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1051-1060;

  8. Schluger, James

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  9. Schweitzer, Edmund

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  10. Schwinger, Robert H. G.

    1. Different Effect of the Ca2+ Sensitizers EMD 57033 and CGP 48506 on Cross-Bridge Cycling in Human Myocardium
      Klara Brixius, Uwe Mehlhorn, Wilhelm Bloch and Robert H. G. Schwinger
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1284-1290;

  11. Shamburger, Susan

    1. Regulation of the Human Norepinephrine Transporter by Cocaine and Amphetamine
      Meng-Yang Zhu, Susan Shamburger, Jing Li and Gregory A. Ordway
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 951-959;

  12. Shebuski, Ronald J.

    1. Meeting Report of the ASPET Colloquium: Functional Genomics
      Anthony R. Porcari and Ronald J. Shebuski
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1291-1295;

  13. Shetler, Timothy J.

    1. Pharmacological Profile of Recombinant, Human Activated Protein C (LY203638) in a Canine Model of Coronary Artery Thrombosis
      Charles V. Jackson, Blanche D. Bailey and Timothy J. Shetler
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 967-971;

  14. Singh, Jai Pal

    1. Fibroblast Growth Factor Protects Nitric Oxide-Induced Apoptosis in Neuronal SHSY-5Y Cells
      Asavari Wagle and Jai Pal Singh
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 889-895;

  15. Smith, Alison

    1. Anticonvulsant and Adverse Effects of Avermectin Analogs in Mice Are Mediated through the γ-Aminobutyric AcidA Receptor
      Gerard R. Dawson, Keith A. Wafford, Alison Smith, George R. Marshall, Peter J. Bayley, James M. Schaeffer, Peter T. Meinke and R. M. McKernan
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1051-1060;

  16. Smith, Timothy

    1. Modulation of Human Monocyte Activities by Tranilast, SB 252218, a Compound Demonstrating Efficacy in Restenosis
      Elizabeth A. Capper, Amy K. Roshak, Brian J. Bolognese, Patricia L. Podolin, Timothy Smith, David L. Dewitt, Karen M. Anderson and Lisa A. Marshall
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1061-1069;

  17. Sobczyk-Kojiro, Katarzyna

    1. Tetrapeptide Derivatives of [d-Pen2,d-Pen5]-Enkephalin (DPDPE) Lacking an N-Terminal Tyrosine Residue Are Agonists at the μ-Opioid Receptor
      Iain J. McFadyen, Katarzyna Sobczyk-Kojiro, Michael J. Schaefer, Jeffrey C. Ho, John R. Omnaas, Henry I. Mosberg and John R. Traynor
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 960-966;

  18. Soper, Brian D.

    1. Protein Kinase C Mediates Lipopolysaccharide- and Phorbol-Induced Nitric-Oxide Synthase Activity and Cellular Injury in the Rat Colon
      Barry L. Tepperman, Qing Chang and Brian D. Soper
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1249-1257;

  19. Sorc, Alenka

    1. Lack of In Vitro Cytotoxicity, Associated to Increased G2-M Cell Fraction and Inhibition of Matrigel Invasion, May Predict In Vivo-Selective Antimetastasis Activity of Ruthenium Complexes
      Sonia Zorzet, Alberta Bergamo, Moreno Cocchietto, Alenka Sorc, Barbara Gava, Enzo Alessio, Elisabetta Iengo and Gianni Sava
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 927-933;

  20. Spooren, Will P. J. M.

    1. Anxiolytic-Like Effects of the Prototypical Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)pyridine in Rodents
      Will P. J. M. Spooren, Annick Vassout, Hans C. Neijt, Rainer Kuhn, Fabrizio Gasparini, Silvain Roux, Roger D. Porsolt and Conrad Gentsch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1267-1275;

  21. Stanwood, Gregg D.

    1. Quantitative Autoradiographic Mapping of Rat Brain Dopamine D3 Binding with [125I]7-OH-PIPAT: Evidence for the Presence of D3 Receptors on Dopaminergic and Nondopaminergic Cell Bodies and Terminals
      Gregg D. Stanwood, Roman P. Artymyshyn, Mei-Ping Kung, Hank F. Kung, Irwin Lucki and Paul McGonigle
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1223-1231;
    2. Differential Regulation of Dopamine D2 and D3 Receptors by Chronic Drug Treatments
      Gregg D. Stanwood, Irwin Lucki and Paul McGonigle
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1232-1240;

T

  1. Tabuchi, Akiko

    1. Repression of Activity-Dependent c-fos and Brain-Derived Neurotrophic Factor mRNA Expression by Pyrethroid Insecticides Accompanying a Decrease in Ca2+ Influx into Neurons
      Lisa Imamura, Hiroshi Hasegawa, Kaori Kurashina, Ayako Hamanishi, Akiko Tabuchi and Masaaki Tsuda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1175-1182;

  2. Tanahashi, Yasutaka

    1. Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery
      Eiji Sasaki, Yasutaka Tanahashi, Yasundo Yamasaki, Nobuyuki Oda, Yoshihisa Nozawa, Hiroshi Terakawa, Kazuhisa Miyoshi, Yoshiyuki Muranaka, Hidekazu Miyake and Naosuke Matsuura
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1043-1050;

  3. Taylor, David A.

    1. Alterations in Neuronal γ-Aminobutyric AcidAReceptor Responsiveness in Genetic Models of Seizure Susceptibility with Different Expression Patterns
      Lance R. Molnar, William W. Fleming and David A. Taylor
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1258-1266;

  4. Tepperman, Barry L.

    1. Protein Kinase C Mediates Lipopolysaccharide- and Phorbol-Induced Nitric-Oxide Synthase Activity and Cellular Injury in the Rat Colon
      Barry L. Tepperman, Qing Chang and Brian D. Soper
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1249-1257;

  5. Terakawa, Hiroshi

    1. Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery
      Eiji Sasaki, Yasutaka Tanahashi, Yasundo Yamasaki, Nobuyuki Oda, Yoshihisa Nozawa, Hiroshi Terakawa, Kazuhisa Miyoshi, Yoshiyuki Muranaka, Hidekazu Miyake and Naosuke Matsuura
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1043-1050;

  6. Terenius, Lars

    1. Dose- and Time-Dependent Bimodal Effects of κ-Opioid Agonists on Locomotor Activity in Mice
      Alexander Kuzmin, Johan Sandin, Lars Terenius and Sven-Ove Ögren
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1031-1042;

  7. Tominaga, Michiaki

    1. Antidiuretic Effects of a Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Rats
      Shigeki Nakamura, Takahiro Hirano, Kenji Tsujimae, Masashi Aoyama, Kazumi Kondo, Yoshitaka Yamamura, Toyoki Mori and Michiaki Tominaga
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1005-1011;

  8. Traynor, John R.

    1. Tetrapeptide Derivatives of [d-Pen2,d-Pen5]-Enkephalin (DPDPE) Lacking an N-Terminal Tyrosine Residue Are Agonists at the μ-Opioid Receptor
      Iain J. McFadyen, Katarzyna Sobczyk-Kojiro, Michael J. Schaefer, Jeffrey C. Ho, John R. Omnaas, Henry I. Mosberg and John R. Traynor
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 960-966;

  9. Tsuda, Masaaki

    1. Repression of Activity-Dependent c-fos and Brain-Derived Neurotrophic Factor mRNA Expression by Pyrethroid Insecticides Accompanying a Decrease in Ca2+ Influx into Neurons
      Lisa Imamura, Hiroshi Hasegawa, Kaori Kurashina, Ayako Hamanishi, Akiko Tabuchi and Masaaki Tsuda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1175-1182;

  10. Tsuji, Kazuhiro

    1. Sequence Analyses of CYP2B Genes and Catalytic Profiles for P450s in Qdj:Sprague-Dawley Rats That Lack Response to the Phenobarbital-Mediated Induction of CYP2B2
      Hideyuki Yamada, Hiromi Matsunaga, Kazuhiro Tsuji, Sanae Matsumoto, Midori Yamamoto, Yuji Ishii, Curtis J. Omiecinski and Kazuta Oguri
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 986-993;

  11. Tsujimae, Kenji

    1. Antidiuretic Effects of a Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Rats
      Shigeki Nakamura, Takahiro Hirano, Kenji Tsujimae, Masashi Aoyama, Kazumi Kondo, Yoshitaka Yamamura, Toyoki Mori and Michiaki Tominaga
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1005-1011;

U

  1. Uckun, Fatih M.

    1. Treatment of Allergic Asthma by Targeting Janus Kinase 3-Dependent Leukotriene Synthesis in Mast Cells with 4-(3′,5′-Dibromo-4′-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)
      Ravi Malaviya, Chun-Lin Chen, Christopher Navara, Rama Malaviya, Xing-Ping Liu, Margaret Keenan, Barbara Waurzyniak and Fatih M. Uckun
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 912-926;

V

  1. Vassout, Annick

    1. Anxiolytic-Like Effects of the Prototypical Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)pyridine in Rodents
      Will P. J. M. Spooren, Annick Vassout, Hans C. Neijt, Rainer Kuhn, Fabrizio Gasparini, Silvain Roux, Roger D. Porsolt and Conrad Gentsch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1267-1275;

  2. Verlaet, Myriam

    1. Roles of Nuclear Factor-κB, p53, and p21/WAF1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis
      Anne-Cécile Hellin, Mohamed Bentires-Alj, Myriam Verlaet, Valérie Benoit, Jacques Gielen, Vincent Bours and Marie-Paule Merville
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 870-878;

W

  1. Wafford, Keith A.

    1. Anticonvulsant and Adverse Effects of Avermectin Analogs in Mice Are Mediated through the γ-Aminobutyric AcidA Receptor
      Gerard R. Dawson, Keith A. Wafford, Alison Smith, George R. Marshall, Peter J. Bayley, James M. Schaeffer, Peter T. Meinke and R. M. McKernan
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1051-1060;

  2. Wagle, Asavari

    1. Fibroblast Growth Factor Protects Nitric Oxide-Induced Apoptosis in Neuronal SHSY-5Y Cells
      Asavari Wagle and Jai Pal Singh
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 889-895;

  3. Wahlestedt, Claes

    1. Supraspinal Antinociceptive Response to [d-Pen2,5]-Enkephalin (DPDPE) Is Pharmacologically Distinct from That to Other δ-Agonists in the Rat
      Graeme L. Fraser, Amynah A. Pradhan, Paul B. S. Clarke and Claes Wahlestedt
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1135-1141;

  4. Waurzyniak, Barbara

    1. Treatment of Allergic Asthma by Targeting Janus Kinase 3-Dependent Leukotriene Synthesis in Mast Cells with 4-(3′,5′-Dibromo-4′-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)
      Ravi Malaviya, Chun-Lin Chen, Christopher Navara, Rama Malaviya, Xing-Ping Liu, Margaret Keenan, Barbara Waurzyniak and Fatih M. Uckun
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 912-926;

  5. Welch, Sandra P.

    1. Comparison of [3H]Glyburide Binding with Opiate Analgesia, Tolerance, and Dependence in ICR and Swiss-Webster Mice
      Vera C. Campbell, William L. Dewey and Sandra P. Welch
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1112-1119;

  6. Wilkins, Diana G.

    1. Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia ,
      Ryan R. Metzger, Heather M. Haughey, Diana G. Wilkins, James W. Gibb, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1077-1085;

  7. Williams, Michael

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In Vitro Characterization and Acute Antinociceptive Effects in the Mouse
      Michael F. Jarvis, Haixia Yu, Kathy Kohlhaas, Karen Alexander, Chih-Hung Lee, Mequin Jiang, Shripad S. Bhagwat, Michael Williams and Elizabeth A. Kowaluk
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1156-1164;
    2. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;
    3. P2 Purinergic Receptors: Modulation of Cell Function and Therapeutic Potential
      Geoffrey Burnstock and Michael Williams
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 862-869;

  8. Winger, Gail

    1. Natural and Artificial Enzymes Against Cocaine. I. Monoclonal Antibody 15A10 and the Reinforcing Effects of Cocaine in Rats ,
      Theodore J. Baird, Shi-Xian Deng, Donald W. Landry, Gail Winger and James H. Woods
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1127-1134;

  9. Wismer, Carol T.

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  10. Witt, Ken A.

    1. Insulin Enhancement of Opioid Peptide Transport across the Blood-Brain Barrier and Assessment of Analgesic Effect
      Ken A. Witt, Jason D. Huber, Richard D. Egleton and Thomas P. Davis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 972-978;

  11. Wong, Viviana

    1. Long-Term Exposure to Ozone Increases Acute Pulmonary Centriacinar Injury by 1-Nitronaphthalene: II. Quantitative Histopathology
      Renee C. Paige, Viviana Wong and Charles G. Plopper
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 942-950;

  12. Wong, Yung H.

    1. Regulation of c-Jun N-Terminal Kinase by the ORL1Receptor through Multiple G Proteins
      Anthony S. L. Chan and Yung H. Wong
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1094-1100;

  13. Woods, James H.

    1. Natural and Artificial Enzymes Against Cocaine. I. Monoclonal Antibody 15A10 and the Reinforcing Effects of Cocaine in Rats ,
      Theodore J. Baird, Shi-Xian Deng, Donald W. Landry, Gail Winger and James H. Woods
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1127-1134;

X

  1. Xiao, Yuhui

    1. Role of Mitochondrial Cytochrome c in Cocaine-Induced Apoptosis in Coronary Artery Endothelial Cells
      Jiale He, Yuhui Xiao, Carlos A. Casiano and Lubo Zhang
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 896-903;

Y

  1. Yamada, Hideyuki

    1. Sequence Analyses of CYP2B Genes and Catalytic Profiles for P450s in Qdj:Sprague-Dawley Rats That Lack Response to the Phenobarbital-Mediated Induction of CYP2B2
      Hideyuki Yamada, Hiromi Matsunaga, Kazuhiro Tsuji, Sanae Matsumoto, Midori Yamamoto, Yuji Ishii, Curtis J. Omiecinski and Kazuta Oguri
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 986-993;

  2. Yamada, Toshimitsu

    1. Effect of a Novel Anti-Inflammatory Compound, YM976, on Antigen-Induced Eosinophil Infiltration into the Lungs in Rats, Mice, and Ferrets
      Motonori Aoki, Masahiro Fukunaga, Minetake Kitagawa, Kazumi Hayashi, Tatsuaki Morokata, Go Ishikawa, Satoshi Kubo and Toshimitsu Yamada
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1149-1155;

  3. Yamamoto, Midori

    1. Sequence Analyses of CYP2B Genes and Catalytic Profiles for P450s in Qdj:Sprague-Dawley Rats That Lack Response to the Phenobarbital-Mediated Induction of CYP2B2
      Hideyuki Yamada, Hiromi Matsunaga, Kazuhiro Tsuji, Sanae Matsumoto, Midori Yamamoto, Yuji Ishii, Curtis J. Omiecinski and Kazuta Oguri
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 986-993;

  4. Yamamura, Yoshitaka

    1. Antidiuretic Effects of a Nonpeptide Vasopressin V2-Receptor Agonist, OPC-51803, Administered Orally to Rats
      Shigeki Nakamura, Takahiro Hirano, Kenji Tsujimae, Masashi Aoyama, Kazumi Kondo, Yoshitaka Yamamura, Toyoki Mori and Michiaki Tominaga
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1005-1011;

  5. Yamasaki, Yasundo

    1. Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery
      Eiji Sasaki, Yasutaka Tanahashi, Yasundo Yamasaki, Nobuyuki Oda, Yoshihisa Nozawa, Hiroshi Terakawa, Kazuhisa Miyoshi, Yoshiyuki Muranaka, Hidekazu Miyake and Naosuke Matsuura
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1043-1050;

  6. Yoshitake, Jun

    1. Protective Effect of S-Nitrosylated α1-Protease Inhibitor on Hepatic Ischemia-Reperfusion Injury
      Norisato Ikebe, Takaaki Akaike, Yoichi Miyamoto, Kazuyuki Hayashida, Jun Yoshitake, Michio Ogawa and Hiroshi Maeda
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 904-911;

  7. Yu, Haixia

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties: I. In Vitro Characterization and Acute Antinociceptive Effects in the Mouse
      Michael F. Jarvis, Haixia Yu, Kathy Kohlhaas, Karen Alexander, Chih-Hung Lee, Mequin Jiang, Shripad S. Bhagwat, Michael Williams and Elizabeth A. Kowaluk
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1156-1164;

Z

  1. Zametkin, Alan

    1. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts
      Mitchel A. Kling, Richard E. Carson, Lisa Borg, Alan Zametkin, John A. Matochik, James Schluger, Peter Herscovitch, Kenner C. Rice, Ann Ho, William C. Eckelman and Mary Jeanne Kreek
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1070-1076;

  2. Zhang, Lubo

    1. Role of Mitochondrial Cytochrome c in Cocaine-Induced Apoptosis in Coronary Artery Endothelial Cells
      Jiale He, Yuhui Xiao, Carlos A. Casiano and Lubo Zhang
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 896-903;

  3. Zhu, Chang Z.

    1. ABT-702 (4-Amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a Novel Orally Effective Adenosine Kinase Inhibitor with Analgesic and Anti-Inflammatory Properties. II. In Vivo Characterization in the Rat
      Elizabeth A. Kowaluk, Joe Mikusa, Carol T. Wismer, Chang Z. Zhu, Edmund Schweitzer, James J. Lynch, Chih-Hung Lee, Meiqun Jiang, Shripad S. Bhagwat, Arthur Gomtsyan, Jeff McKie, Bryan F. Cox, James Polakowski, Glenn Reinhart, Michael Williams and Michael F. Jarvis
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1165-1174;

  4. Zhu, Meng-Yang

    1. Regulation of the Human Norepinephrine Transporter by Cocaine and Amphetamine
      Meng-Yang Zhu, Susan Shamburger, Jing Li and Gregory A. Ordway
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 951-959;

  5. Zorzet, Sonia

    1. Lack of In Vitro Cytotoxicity, Associated to Increased G2-M Cell Fraction and Inhibition of Matrigel Invasion, May Predict In Vivo-Selective Antimetastasis Activity of Ruthenium Complexes
      Sonia Zorzet, Alberta Bergamo, Moreno Cocchietto, Alenka Sorc, Barbara Gava, Enzo Alessio, Elisabetta Iengo and Gianni Sava
      Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 927-933;
Back to top

In this issue